Wells Fargo Maintains Overweight on CVS Health, Raises Price Target to $103

Benzinga Newsdesk www.benzinga.com Positive 78.5%

Neg 0% Neu 0% Pos 78.5%

Wells Fargo analyst Stephen Baxter maintains CVS Health (NYSE:CVS) with a Overweight and raises the price target from $102 to $103.